Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Operating Activities
Net Loss	$ (1,281,783)	$ (3,174,822)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization	2,180	1,290
Accrued interest		16,835
Finance charges and interest paid in shares		24,824
Professional fees paid in shares		29,374
Stock based compensation		1,360,000
Accretion of debt discount		2,971
Loss on settlement of debt	495,943	1,046,322
Loss on derivative		484,720
Total items not involving cash flow from operating activities	(783,659)	(208,486)
Changes in operating assets and liabilities	739,000	126,600
Net cash used in operating activities	(44,659)	(81,886)
Cash Flows from Investing Activities
Purchase of property and equipment		(14,875)
Net cash used in investing activities		(14,875)
Financing Activities
Proceeds from issuance of stock for cash	175,000
Repayment of overdraft		(870)
Proceeds from share subscriptions receivable		1,750
Proceeds from notes payable		53,389
Proceeds from shareholder loans		22,536
Proceeds from loan payable		19,262
Repayment of promissory notes		(7,658)
Net cash provided by financing activities	175,000	88,409
Effects of Foreign Currency Translation	(38,410)	8,352
Change in cash	91,931
Cash and cash equivalents - beginning of year	66,961
Cash and cash equivalents end of year	158,892
Supplemental disclosure of cash flow information:
Interest paid	16,604
Supplemental Disclosure of non-cash investing and financing Activities
Shares issued for settlement of notes and accounts payable	172,056
Shares issued for consulting agreements	393,750
Common shares issued to CEO		1,460,000
Common shares issued as finance charges		21,000
Conversion of promissory notes		1,314,904
Increase (decrease) in share subscriptions payable	(589,694)	1,231,079
Increase in share subscriptions receivable		$ 39,415